sulfasalazine

(redirected from Salazopyrin)
Also found in: Medical.

sul·fa·sal·a·zine

 (sŭl′fə-săl′ə-zēn′)
n.
A sulfa drug, C18H14N4O5S, used to treat ulcerative colitis.

[sulfa(pyridine), one of its constituents + sal(icylic acid) + az(o)- + -ine.]
Translations

sulfasalazine

n sulfasalazina
Mentioned in ?
References in periodicals archive ?
All patients diagnosed with AS were taking sulfasalazine (Salazopyrin).
RA Control patients subjects P (n = 80) (n = 30) Age (yrs) 52.9 [+ or -] 10.6 50.1 [+ or -] 8 NS Female (%) 89 87 NS Diabetes (%) 12 -- -- Hypertension 20 -- -- (%) Dyslipidemia 64 -- (%) Erythrocyte sedimentation 39.6 [+ or -] 27.2 9.8 [+ or -] 3.2 P < 0.001 rate (ESR) (mm/H) Disease 11.7[+ or -]8.2 duration (yrs) Swollen joint 2.4 [+ or -] 4.3 count (SJC) Tender joint 16[+ or -]10 count (TJC) HAQ score 1.5 [+ or -] 0.9 Positive anticyclic citrullinated 62.5 peptides (anti-CCPs, %) Positive IgM 68.7 rheumatoid factor (%) DAS28 5.5 [+ or -] 1.3 Remission (%) 0 Low (%) 0 Moderate (%) 41 Active (%) 59 Medication Methotrexate 85 (%) Arava (%) 8.7 Salazopyrin (%) 12.5 Data represent means [+ or -] SD or percentages.
Tenders are invited for Each Tab Cap Contains Salazopyrin 500 Mg In Strip / Blister Pack Only.
Fifty-five percent of the participants was taking methotrexate (10-25 mg/week) (n=26), 19% was taking salazopyrin (2 gr/day) (n=9), 59.6% was taking steroids (2-6 mg/day) (n=28), 44.7% was taking hydroxychloroquine (200-400 mg/day) (n=21), 2.1% was taking leflunomide (20 mg/day) (n=2), 2.1% was taking biological drugs (n=1), and 78.7% was taking combined treatment (methotrexate, salazopyrin, steroids) (n=36).
The synthetic disease modifying antirheumatic drugs (DMARDS), including methotrexate, salazopyrin, and leflunomide, are active therapy for PsA or AS with peripheral arthritis but no efficacy for axial SpA [8-10].